Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.79 - $1.91 $16,429 - $39,722
-20,797 Reduced 27.77%
54,106 $44,000
Q4 2022

Feb 14, 2023

BUY
$1.41 - $2.5 $3,331 - $5,907
2,363 Added 3.26%
74,903 $116,000
Q3 2022

Nov 14, 2022

BUY
$1.66 - $2.79 $873 - $1,467
526 Added 0.73%
72,540 $125,000
Q2 2022

Aug 12, 2022

BUY
$1.44 - $3.98 $65,908 - $182,164
45,770 Added 174.4%
72,014 $125,000
Q1 2022

May 16, 2022

SELL
$2.97 - $5.2 $4,600 - $8,054
-1,549 Reduced 5.57%
26,244 $94,000
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $19,640 - $29,362
3,936 Added 16.5%
27,793 $139,000
Q3 2021

Nov 15, 2021

SELL
$7.16 - $9.69 $8,935 - $12,093
-1,248 Reduced 4.97%
23,857 $171,000
Q2 2021

Aug 10, 2021

SELL
$6.23 - $10.03 $23,300 - $37,512
-3,740 Reduced 12.97%
25,105 $233,000
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $4,457 - $8,581
506 Added 1.79%
28,845 $268,000
Q4 2020

Feb 12, 2021

BUY
$8.5 - $12.85 $240,881 - $364,156
28,339 New
28,339 $251,000
Q2 2019

Aug 13, 2019

SELL
$2.29 - $4.1 $121,239 - $217,066
-52,943 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$3.34 - $5.1 $24,899 - $38,020
-7,455 Reduced 12.34%
52,943 $197,000
Q4 2018

Feb 05, 2019

SELL
$3.89 - $6.11 $169,627 - $266,432
-43,606 Reduced 41.93%
60,398 $242,000
Q3 2018

Nov 14, 2018

SELL
$3.92 - $5.58 $291,495 - $414,934
-74,361 Reduced 41.69%
104,004 $578,000
Q2 2018

Aug 10, 2018

BUY
$3.88 - $5.16 $13,902 - $18,488
3,583 Added 2.05%
178,365 $699,000
Q1 2018

May 14, 2018

BUY
$4.05 - $5.69 $380,424 - $534,473
93,932 Added 116.18%
174,782 $823,000
Q4 2017

Feb 14, 2018

BUY
$4.13 - $6.68 $163,618 - $264,641
39,617 Added 96.08%
80,850 $334,000
Q3 2017

Nov 14, 2017

BUY
$5.36 - $6.37 $20,217 - $24,027
3,772 Added 10.07%
41,233 $261,000
Q2 2017

Aug 14, 2017

BUY
N/A
37,461
37,461 $294,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $496M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.